Today at the 8th annual Heart in Diabetes we’re sharing more information about our GRACE clinical trial data in our presentation: Medical Treatment of Hypercortisolism with Relacorilant: Final Results of the Phase 3 GRACE Study. Metabolic Endocrine Education Foundation #CortisolModulation #8thHeartinDiabetes #HID2024
Corcept Therapeutics
Biotechnology Research
Menlo Park, CA 33,323 followers
Pioneering the discovery and development of cortisol modulators.
About us
At the center of discovery and development of cortisol modulation. Our mission is to unlock the potential of cortisol and revolutionize the treatment of serious diseases. For the last 25 years, we’ve led the way in the research and development of selective glucocorticoid receptors (GR) antagonists, molecules that alter GR and regulate cortisol levels. In 2012, we received FDA approval of a groundbreaking cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushing’s syndrome). Today, global partnerships and collaborations form the bedrock of our robust development programs, including more than 500 GR antagonists for conditions spanning oncology, endocrine, and an array of metabolic disorders. What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease. We embrace possibility. We are Corcept.
- Website
-
http://www.corcept.com
External link for Corcept Therapeutics
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Menlo Park, CA
- Type
- Public Company
- Founded
- 1998
Locations
-
Primary
Get directions
149 Commonwealth Dr
Menlo Park, CA 94025, US
Employees at Corcept Therapeutics
Updates
-
Highlighting contributions from scientists who identify as LGBTQ+ not only breaks stereotypes but also provides crucial role models for future generations, promoting inclusivity and innovation in scientific communities. To honor #PrideMonth, Corcept celebrates the work of Dr. Neena Schwartz, an endocrinologist who identified as a lesbian. Learn more about her life here: https://bit.ly/3x0mY3D
-
-
The upcoming presentations on GRACE data at #ENDO2024 and Heart in Diabetes will offer more context for providers who manage patients living with #hypercortisolism https://bit.ly/4aLaVoz Endocrine Society Metabolic Endocrine Education Foundation #8thHeartinDiabetes #HID2024 #CortisolModulation #Endocrinology #CushingsSyndrome #CortisolModulation
-
-
We couldn’t let #ALSAwarenessMonth wrap without our annual company walk! The event gives our employees the opportunity to raise critical awareness about ALS – and reminds us all of the importance of our work that aims to address this serious disease. We heard moving and educational presentations from Sheri Strahl at the ALS Network and Dr. Michael Robinson, who spoke about the first-hand challenges faced by people before and after diagnosis. We remain in awe of the critical advocacy work led by ALS Network, Michael and the many individuals and groups dedicating their lives to helping people with ALS.
-
-
Tomorrow kicks off the American Society of Clinical Oncology (ASCO) Annual Meeting, where professionals working in #Oncology spend time connecting and collaborating. Find Corcept at Booth #14157 to learn more about the potential role of our proprietary selective #CortisolModulator in platinum-resistant ovarian cancer. #ASCO24 #OvarianCancer #ClinicalResearch #Phase3
-
-
Today we’re watching a moving and inspirational documentary, For Love & Life: No Ordinary Campaign. The film documents the advocacy journey of I AM ALS co-founders Brian Wallach and Sandra Abrevaya following Brian’s ALS diagnosis. Check it out on Prime Video. https://amzn.to/3UFHAG3 #ALSAwarenessMonth
-
We are excited to share news about our GRACE clinical trial and look forward to providing more insights about this pivotal Phase 3 study of patients with #hypercortisolism soon. Read more in today’s press release: https://bit.ly/45gVLqh #CortisolModulation #ClinicalTrial
-
-
Will you be at #ENDO2024 this year? If so, we’ll see you at Booth #732. Endocrine Society #CortisolModulation #Endocrinology
-
-
Collaboration is at the heart of what we do at Corcept. Together, we are working to revolutionize the treatment of serious diseases. Learn more: https://www.corcept.com/ #endocrinology #oncology #metabolism #neurology #biotech
-
At Corcept we are focused on unlocking the potential of cortisol modulation to treat serious diseases. We are grateful for researchers in the endocrinology field working to educate the healthcare community on cortisol’s role in the body. Read more about cortisol here:
A Lot of What You’ve Heard About Cortisol Is Wrong
wsj.com